UNSPSC 51292006: Dapoxetine

This classification denotes a selective serotonin reuptake inhibitor and antidepressant agent with the molecular formula C21H23NO, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier GB2433A4M3, chemically known as benzenemethanamine, n,n-dimethyl-alpha-(2-(1-naphthalenyloxy)ethyl)-, (+)- but generally known as dapoxetine, which bears US NIH Compound Identifier 71353. European Medicines Agency schedules Dapoxetine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06908MIG.

UNSPSC 51292006 Dapoxetine is a Commodity code that nominally identifies a specific pharmaceutical product, but the recent state and local procurement activity tagged under this code shows a significant mismatch with the code's intended scope. The single recent opportunity on record — Seminole County, Florida's IFB 60459723LAS — solicits Naloxone and Safe Drug Deactivation Systems, neither of which aligns with dapoxetine's pharmaceutical classification. Seminole County's procurement calls for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through a competitive IFB process, with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, fixed-fee pricing, and standard compliance requirements including drug-free workplace certification, E-Verify compliance, and insurance coverage (workers' compensation, commercial general liability, and professional liability). The opportunity indicates potential FEMA funding with attendant federal compliance obligations such as adherence to the Clean Air Act and Federal Water Pollution Control Act.

The code shows limited recent activity in state and local procurement, with only Seminole County, Florida represented in the current opportunities block. The mismatch between the code's nominal pharmaceutical scope and the actual goods being solicited suggests either a tagging error in the county's procurement system or a narrow application of this UNSPSC code to a specific regional health initiative. Without additional recent opportunities under this code from other jurisdictions, the geographic spread and issuing-body mix cannot be characterized. Business development professionals evaluating this code should verify whether their product or service offering aligns with dapoxetine itself, or seek clarification on why state and local procurement offices are assigning this code to Naloxone and drug deactivation equipment purchases.